Ryan Novince
Internal Medicine · Tallahassee, FLNPI 1164865259
Payments from drug & device makers
Across 63 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$160
- Sanofi-aventis U.S. LLC$78
- Novo Nordisk$72
- AbbVie$71
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$58
- Boehringer Ingelheim$54
- plus $598 from 21 others
What the payments were for
- Food & beverage$1,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,092 in reported general payments places this provider in the 70th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $24,286 |
| Duloxetine Hcl | 31 | $1,646 |
| Atorvastatin Calcium | 117 | $1,078 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $892 |
| Metoprolol Succinate | 46 | $711 |
| Rosuvastatin Calcium | 69 | $635 |
| Losartan Potassium | 57 | $586 |
| Gabapentin | 44 | $582 |
| Omeprazole | 46 | $564 |
| Lisinopril | 78 | $503 |
| Levothyroxine Sodium | 51 | $456 |
| Ezetimibe | 24 | $417 |
| Glipizide ErGlipizide | 40 | $363 |
| Potassium Chloride | 19 | $309 |
| Metformin Hcl ErMetformin Hcl | 33 | $290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $19 | $24,28622 claims |
| Almatica Pharma LLCSertraline Hcl | $40 | $14127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Tallahassee
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.